[HTML][HTML] Cyclophosphamide versus placebo in scleroderma lung disease

…, PJ Clements, J Goldin, MD Roth… - … England Journal of …, 2006 - Mass Medical Soc
Background We conducted a double-blind, randomized, placebo-controlled trial to determine
the effects of oral cyclophosphamide on lung function and health-related symptoms in …

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group …

DP Tashkin, MD Roth, PJ Clements… - The lancet Respiratory …, 2016 - thelancet.com
Background 12 months of oral cyclophosphamide has been shown to alter the progression
of scleroderma-related interstitial lung disease when compared with placebo. However, …

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor …

…, DJ Chute, PS Mischel, TF Cloughesy, MD Roth - Clinical Cancer …, 2005 - AACR
Purpose: We previously reported that autologous dendritic cells pulsed with acid-eluted tumor
peptides can stimulate T cell–mediated antitumor immune responses against brain tumors …

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease

…, R Elashoff, PJ Clements, MD Roth… - American journal of …, 2007 - atsjournals.org
Rationale: The Scleroderma Lung Study enrolled 158 patients with scleroderma-related
interstitial lung disease in a placebo-controlled trial of oral cyclophosphamide (CYC). Although …

Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2

…, DA Bouis, MV Norgard, MD Roth… - The Journal of …, 2001 - journals.aai.org
The ability of dendritic cells (DC) to initiate immune responses in naive T cells is dependent
upon a maturation process that allows the cells to develop their potent Ag-presenting …

Interferon‐α and granulocyte‐macrophage colony‐stimulating factor differentiate peripheral blood monocytes into potent antigen‐presenting cells

…, AN Park, L Tran, MD Roth… - Journal of leukocyte …, 1998 - Wiley Online Library
The diverse roles of interferon‐α (IFN‐α) in regulating the immune response to infectious
agents suggested that it might affect dendritic cell (DC) development. Peripheral blood …

Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco

SEG Fligiel, MD Roth, EC Kleerup, SH Barsky… - Chest, 1997 - Elsevier
Background Marijuana and alkaloidal cocaine (“crack”) are the two most commonly smoked
substances in the United States after tobacco. While regular tobacco smoking has been …

Δ-9-Tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway

…, S Sharma, M Stolina, B Gardner, MD Roth… - The Journal of …, 2000 - journals.aai.org
In this study, we show that Δ-9-tetrahydrocannabinol (THC), the major psychoactive component
of marijuana, suppresses host immune reactivity against lung cancer. In two different …

Airway inflammation in young marijuana and tobacco smokers

MD Roth, A Arora, SH Barsky, EC Kleerup… - American journal of …, 1998 - atsjournals.org
… Correspondence and requests for reprints should be addressed to Michael D. Roth, MD,
Division of Pulmonary and Critical Care, Department of Medicine, UCLA School of Medicine, …

Marijuana and cocaine impair alveolar macrophage function and cytokine production

…, AN Park, SM Dubinett, MD Roth - American journal of …, 1997 - atsjournals.org
Use of marijuana and cocaine is on the rise in the United States. Although pulmonary toxicity
from these drugs has occasionally been reported, little is known about their effects on the …